ION BLUE EncyclopediaHigh Evidence

Matrixyl 3000

Matrixyl 3000 is a cosmetic peptide blend of palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7. A cited 12-week human study of a multi-component formula containing both peptides reported measured skin improvements; because the formula included additional actives, effects cannot be attributed to the peptide blend alone.

Evidence: Low

Reading time:1 min
Citations:1
Updated:June 29, 2026

Type

Peptide

Direct Answer

Matrixyl 3000 is a cosmetic peptide blend of palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7. A cited 12-week human study of a multi-component formula containing both peptides reported measured skin improvements; because the formula included additional actives, effects cannot be attributed to the peptide blend alone.

Summary Table

Evidence Level

High

Key Information

Classification

Signal Peptides1 Mechanisms

Key Takeaways

  • Matrixyl 3000 is a blend of palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7
  • Cited human evidence is from a multi-ingredient formula
  • Effects cannot be attributed to the peptide blend alone

Scientific Overview

In Plain English

Matrixyl 3000 is a blend of two peptides (palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7) used in anti-aging skincare. A 12-week human study of a product containing these peptides plus other ingredients reported better skin hydration, elasticity, and fewer visible fine lines, but the product had several actives, so the result is for the whole formula.

Scientific Details

Matrixyl 3000 combines palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7. A 12-week controlled human study of a multi-component eye cream containing both peptides (with yeast and rice ferment filtrate and N-acetylneuraminic acid) reported improvements in measured hydration, elasticity, and the appearance of fine lines and wrinkles, alongside in vitro fibroblast proliferation and collagen and elastin synthesis for the active complex. The multi-ingredient design means effects cannot be attributed to the peptide blend alone.

How It Works

The blend is described in relation to fibroblast activity and matrix-protein synthesis; cited evidence evaluated it within a multi-component formulation rather than in isolation.

Mechanism of Action

Matrix-protein signaling (formulation-level)

cell

In a multi-component study, the active complex was associated with fibroblast proliferation and collagen and elastin synthesis in vitro.

Evidence Level

Human Evidence

A 12-week controlled study of a multi-ingredient formula containing the blend reported improvements in measured hydration, elasticity, and fine-line and wrinkle appearance.

Cell Evidence

In vitro work reported fibroblast proliferation and collagen and elastin synthesis for the active complex.

Limitations

Evidence is from a multi-ingredient formulation; effects cannot be attributed to the Matrixyl 3000 peptide blend alone. The cited study is manufacturer-funded (Mageline Biology Tech).

References

  1. Comprehensive evaluation of the efficacy and safety of a new multi-component anti-aging topical eye cream. Skin Research and Technology.Human Studydoi:10.1111/srt.13790

Alternative Names

  • Palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7
  • Matrixyl 3000 peptide blend

Claim Boundaries

ION BLUE is an educational research aggregator. This content summarizes published scientific literature. It is not medically reviewed, is not medical advice, and is not a recommendation to use any substance. Several peptides discussed are research chemicals not approved for human use. Consult a licensed healthcare provider. Cited evidence is from a multi-ingredient formula; this entry does not attribute effects to the peptide blend alone and is not a recommendation to use it.

This page summarizes published research and is for informational purposes only; it is not medical advice.